Novartis wins approval: First malaria treatment drug for newborns and babies is here

In a historic move, Swissmedic has approved Coartem Baby, the first malaria treatment specifically for newborns and young infants. This cherry-flavored, dispersible tablet addresses a critical treatment gap for babies under 4.5 kg, who previously faced overdose risks with adult formulations.

Most Recent